Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Stenosis | 16 | 2019 | 34 | 4.780 |
Why?
|
Fractional Flow Reserve, Myocardial | 16 | 2018 | 18 | 4.460 |
Why?
|
Graft Occlusion, Vascular | 15 | 2014 | 16 | 4.380 |
Why?
|
Pulmonary Embolism | 6 | 2023 | 32 | 4.120 |
Why?
|
Saphenous Vein | 17 | 2014 | 23 | 4.010 |
Why?
|
Coronary Artery Bypass | 17 | 2023 | 43 | 4.010 |
Why?
|
Takotsubo Cardiomyopathy | 11 | 2020 | 12 | 3.960 |
Why?
|
Myocardial Infarction | 21 | 2023 | 225 | 3.770 |
Why?
|
Coronary Occlusion | 8 | 2013 | 9 | 3.490 |
Why?
|
Stents | 25 | 2020 | 59 | 3.450 |
Why?
|
Coronary Angiography | 33 | 2021 | 90 | 3.050 |
Why?
|
Treatment Outcome | 44 | 2023 | 1369 | 2.850 |
Why?
|
Thrombectomy | 7 | 2023 | 13 | 2.360 |
Why?
|
Hospitalization | 13 | 2022 | 388 | 2.320 |
Why?
|
Drug-Eluting Stents | 17 | 2019 | 28 | 2.210 |
Why?
|
Stroke | 7 | 2023 | 286 | 2.060 |
Why?
|
Coronary Vessels | 6 | 2013 | 85 | 2.050 |
Why?
|
Aortic Valve Stenosis | 6 | 2019 | 23 | 2.020 |
Why?
|
Inpatients | 9 | 2020 | 74 | 1.980 |
Why?
|
Coronary Artery Disease | 10 | 2019 | 142 | 1.950 |
Why?
|
Thrombolytic Therapy | 6 | 2023 | 17 | 1.840 |
Why?
|
Heart Arrest | 5 | 2023 | 35 | 1.830 |
Why?
|
Humans | 120 | 2023 | 37093 | 1.830 |
Why?
|
Aortic Valve | 5 | 2021 | 23 | 1.770 |
Why?
|
Male | 81 | 2023 | 20025 | 1.720 |
Why?
|
Middle Aged | 58 | 2023 | 10129 | 1.660 |
Why?
|
Sepsis | 4 | 2019 | 80 | 1.620 |
Why?
|
Ultrasonography, Interventional | 10 | 2023 | 18 | 1.570 |
Why?
|
Atrial Fibrillation | 4 | 2020 | 101 | 1.570 |
Why?
|
Hospital Mortality | 12 | 2022 | 187 | 1.560 |
Why?
|
Cannabis | 4 | 2022 | 79 | 1.510 |
Why?
|
Coronary Restenosis | 10 | 2012 | 25 | 1.360 |
Why?
|
Aged | 46 | 2021 | 6741 | 1.300 |
Why?
|
Heart Valve Prosthesis | 3 | 2013 | 18 | 1.300 |
Why?
|
United States | 30 | 2023 | 4223 | 1.150 |
Why?
|
Acute Coronary Syndrome | 5 | 2021 | 39 | 1.110 |
Why?
|
Thrombosis | 7 | 2013 | 63 | 1.110 |
Why?
|
Female | 51 | 2023 | 20969 | 1.100 |
Why?
|
Hypertension | 4 | 2022 | 796 | 1.030 |
Why?
|
Hemodynamics | 6 | 2020 | 91 | 0.990 |
Why?
|
Embolectomy | 2 | 2020 | 2 | 0.950 |
Why?
|
Collateral Circulation | 6 | 2014 | 9 | 0.950 |
Why?
|
Propensity Score | 4 | 2019 | 38 | 0.890 |
Why?
|
Young Adult | 17 | 2023 | 4268 | 0.860 |
Why?
|
Mood Disorders | 3 | 2020 | 48 | 0.860 |
Why?
|
Dyslipidemias | 3 | 2020 | 43 | 0.860 |
Why?
|
Obesity | 3 | 2020 | 1067 | 0.850 |
Why?
|
Coronary Disease | 4 | 2014 | 124 | 0.840 |
Why?
|
Prevalence | 12 | 2020 | 1455 | 0.810 |
Why?
|
Heart Failure | 3 | 2017 | 235 | 0.790 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2012 | 2 | 0.780 |
Why?
|
Marijuana Abuse | 1 | 2022 | 91 | 0.780 |
Why?
|
Databases, Factual | 8 | 2020 | 291 | 0.760 |
Why?
|
Chronic Disease | 9 | 2014 | 484 | 0.740 |
Why?
|
Peripheral Vascular Diseases | 1 | 2020 | 10 | 0.740 |
Why?
|
Adult | 26 | 2023 | 11712 | 0.740 |
Why?
|
Heart Transplantation | 2 | 2012 | 42 | 0.730 |
Why?
|
Retrospective Studies | 13 | 2023 | 2026 | 0.730 |
Why?
|
Pulmonary Artery | 1 | 2020 | 31 | 0.730 |
Why?
|
Coronary Vessel Anomalies | 2 | 2012 | 5 | 0.720 |
Why?
|
Myocardial Ischemia | 3 | 2012 | 75 | 0.710 |
Why?
|
Cocaine | 1 | 2022 | 232 | 0.710 |
Why?
|
Adolescent | 14 | 2023 | 5363 | 0.680 |
Why?
|
Diabetes Mellitus | 4 | 2020 | 485 | 0.680 |
Why?
|
Coronary Thrombosis | 2 | 2012 | 6 | 0.680 |
Why?
|
Tobacco Use Disorder | 1 | 2022 | 237 | 0.670 |
Why?
|
Mental Disorders | 2 | 2020 | 309 | 0.660 |
Why?
|
Risk Factors | 19 | 2023 | 3562 | 0.650 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 2 | 2009 | 2 | 0.650 |
Why?
|
Aged, 80 and over | 14 | 2020 | 2379 | 0.650 |
Why?
|
Electrocardiography | 5 | 2012 | 156 | 0.600 |
Why?
|
Platelet Aggregation Inhibitors | 7 | 2014 | 62 | 0.570 |
Why?
|
Depression | 2 | 2019 | 712 | 0.530 |
Why?
|
Atherectomy, Coronary | 3 | 2019 | 3 | 0.520 |
Why?
|
Anxiety | 2 | 2019 | 754 | 0.510 |
Why?
|
Smoking | 2 | 2020 | 940 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 5 | 2018 | 214 | 0.510 |
Why?
|
Heart Atria | 3 | 2020 | 26 | 0.510 |
Why?
|
Substance-Related Disorders | 1 | 2022 | 730 | 0.500 |
Why?
|
Ventricular Function, Left | 2 | 2013 | 96 | 0.500 |
Why?
|
Adenosine | 2 | 2012 | 59 | 0.500 |
Why?
|
Comorbidity | 7 | 2021 | 623 | 0.490 |
Why?
|
Heart Ventricles | 3 | 2012 | 110 | 0.490 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2013 | 85 | 0.490 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2018 | 19 | 0.480 |
Why?
|
Myocardium | 2 | 2013 | 235 | 0.470 |
Why?
|
Postoperative Complications | 5 | 2019 | 210 | 0.470 |
Why?
|
Severity of Illness Index | 7 | 2019 | 610 | 0.470 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2011 | 69 | 0.460 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2013 | 22 | 0.460 |
Why?
|
Tissue Donors | 1 | 2013 | 44 | 0.450 |
Why?
|
Arteries | 1 | 2013 | 65 | 0.450 |
Why?
|
Follow-Up Studies | 8 | 2019 | 974 | 0.450 |
Why?
|
Ventricular Septum | 1 | 2012 | 1 | 0.430 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2013 | 33 | 0.430 |
Why?
|
Heart Neoplasms | 1 | 2012 | 7 | 0.430 |
Why?
|
Sarcoidosis | 1 | 2012 | 11 | 0.430 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 17 | 0.430 |
Why?
|
Registries | 3 | 2023 | 335 | 0.420 |
Why?
|
Incidence | 8 | 2021 | 922 | 0.420 |
Why?
|
Angina Pectoris, Variant | 1 | 2012 | 1 | 0.420 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 53 | 0.420 |
Why?
|
Lymph Nodes | 1 | 2012 | 67 | 0.420 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 3 | 0.410 |
Why?
|
Graft Rejection | 1 | 2012 | 38 | 0.410 |
Why?
|
Embolism, Cholesterol | 1 | 2011 | 1 | 0.410 |
Why?
|
Mammary Arteries | 1 | 2011 | 3 | 0.410 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2011 | 10 | 0.410 |
Why?
|
Time Factors | 12 | 2019 | 1742 | 0.410 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 24 | 0.410 |
Why?
|
Catheterization | 1 | 2011 | 24 | 0.410 |
Why?
|
Cardiomyopathies | 1 | 2012 | 56 | 0.400 |
Why?
|
Decision Making | 1 | 2013 | 203 | 0.390 |
Why?
|
Disease Progression | 3 | 2017 | 601 | 0.390 |
Why?
|
Coronary Sinus | 1 | 2010 | 1 | 0.380 |
Why?
|
Arteriovenous Fistula | 1 | 2010 | 12 | 0.380 |
Why?
|
Anticoagulants | 2 | 2023 | 102 | 0.380 |
Why?
|
Heart Septum | 1 | 2010 | 6 | 0.370 |
Why?
|
Anastomosis, Surgical | 1 | 2010 | 21 | 0.360 |
Why?
|
Myasthenia Gravis | 2 | 2020 | 4 | 0.360 |
Why?
|
Carotid Stenosis | 2 | 2020 | 13 | 0.360 |
Why?
|
Anaphylaxis | 2 | 2020 | 14 | 0.350 |
Why?
|
Drug Prescriptions | 1 | 2010 | 41 | 0.350 |
Why?
|
Cardiotonic Agents | 1 | 2010 | 37 | 0.350 |
Why?
|
Survival Rate | 5 | 2019 | 311 | 0.340 |
Why?
|
Shock, Cardiogenic | 4 | 2023 | 10 | 0.340 |
Why?
|
Prosthesis Design | 7 | 2014 | 24 | 0.340 |
Why?
|
Paclitaxel | 6 | 2011 | 50 | 0.340 |
Why?
|
Aorta | 1 | 2010 | 167 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 2 | 2020 | 36 | 0.330 |
Why?
|
Echocardiography | 4 | 2021 | 144 | 0.330 |
Why?
|
Coronavirus Infections | 2 | 2020 | 68 | 0.320 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 76 | 0.320 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 25 | 0.310 |
Why?
|
Neoplasms | 2 | 2018 | 1103 | 0.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2016 | 77 | 0.300 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 664 | 0.260 |
Why?
|
Ephedra | 1 | 2005 | 1 | 0.260 |
Why?
|
Heart Defects, Congenital | 2 | 2020 | 60 | 0.250 |
Why?
|
Risk Assessment | 6 | 2019 | 753 | 0.250 |
Why?
|
Plant Preparations | 1 | 2005 | 27 | 0.250 |
Why?
|
Case-Control Studies | 3 | 2019 | 1130 | 0.240 |
Why?
|
Acute Disease | 2 | 2021 | 147 | 0.240 |
Why?
|
Death, Sudden, Cardiac | 1 | 2023 | 21 | 0.230 |
Why?
|
Tricuspid Atresia | 1 | 2003 | 1 | 0.230 |
Why?
|
Tissue Plasminogen Activator | 1 | 2023 | 22 | 0.230 |
Why?
|
Carotid Artery, Internal | 2 | 2020 | 6 | 0.230 |
Why?
|
Metals | 4 | 2011 | 98 | 0.220 |
Why?
|
Postoperative Hemorrhage | 1 | 2023 | 14 | 0.220 |
Why?
|
Benzocaine | 1 | 2003 | 1 | 0.220 |
Why?
|
Methemoglobinemia | 1 | 2003 | 2 | 0.220 |
Why?
|
Echocardiography, Transesophageal | 1 | 2003 | 20 | 0.220 |
Why?
|
Anesthetics, Local | 1 | 2003 | 22 | 0.220 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2003 | 45 | 0.220 |
Why?
|
Dietary Supplements | 1 | 2005 | 208 | 0.220 |
Why?
|
Cardiomegaly | 1 | 2003 | 41 | 0.220 |
Why?
|
Tomography, Optical Coherence | 2 | 2012 | 31 | 0.210 |
Why?
|
Hemorrhage | 2 | 2013 | 45 | 0.210 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 77 | 0.210 |
Why?
|
Atherosclerosis | 2 | 2016 | 134 | 0.210 |
Why?
|
Cohort Studies | 4 | 2019 | 1492 | 0.210 |
Why?
|
Cost of Illness | 2 | 2019 | 76 | 0.210 |
Why?
|
Psychotic Disorders | 2 | 2020 | 55 | 0.210 |
Why?
|
Equipment Design | 2 | 2013 | 124 | 0.200 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 217 | 0.200 |
Why?
|
Myxoma | 1 | 2021 | 5 | 0.200 |
Why?
|
Length of Stay | 2 | 2020 | 185 | 0.200 |
Why?
|
Weather | 1 | 2021 | 8 | 0.190 |
Why?
|
Retreatment | 3 | 2012 | 9 | 0.190 |
Why?
|
Calcinosis | 1 | 2021 | 59 | 0.190 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 48 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 643 | 0.190 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2020 | 1 | 0.190 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 17 | 0.190 |
Why?
|
Shock | 1 | 2020 | 2 | 0.180 |
Why?
|
Takayasu Arteritis | 1 | 2020 | 1 | 0.180 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 13 | 0.180 |
Why?
|
Mediastinal Neoplasms | 1 | 2020 | 6 | 0.180 |
Why?
|
Prediabetic State | 1 | 2021 | 53 | 0.180 |
Why?
|
Antithrombins | 1 | 2020 | 3 | 0.180 |
Why?
|
Sex Factors | 2 | 2020 | 898 | 0.180 |
Why?
|
Heparin | 1 | 2020 | 35 | 0.180 |
Why?
|
Health Resources | 1 | 2020 | 32 | 0.180 |
Why?
|
Hospitals | 1 | 2020 | 86 | 0.170 |
Why?
|
Age Factors | 2 | 2020 | 1033 | 0.170 |
Why?
|
Patient Admission | 1 | 2019 | 41 | 0.170 |
Why?
|
Angiodysplasia | 1 | 2019 | 3 | 0.170 |
Why?
|
Logistic Models | 3 | 2016 | 923 | 0.170 |
Why?
|
Epilepsy | 1 | 2019 | 43 | 0.170 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 27 | 0.160 |
Why?
|
Age Distribution | 1 | 2019 | 225 | 0.160 |
Why?
|
Sex Distribution | 1 | 2019 | 215 | 0.160 |
Why?
|
Alcoholism | 1 | 2021 | 240 | 0.160 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 47 | 0.160 |
Why?
|
Prospective Studies | 6 | 2023 | 1378 | 0.160 |
Why?
|
Indians, North American | 1 | 2020 | 159 | 0.150 |
Why?
|
Survivors | 1 | 2019 | 136 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2020 | 308 | 0.150 |
Why?
|
Brain Ischemia | 1 | 2019 | 184 | 0.150 |
Why?
|
Digoxin | 1 | 2017 | 6 | 0.150 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2017 | 12 | 0.150 |
Why?
|
Marijuana Smoking | 1 | 2018 | 85 | 0.140 |
Why?
|
Angina, Unstable | 2 | 2012 | 8 | 0.140 |
Why?
|
Child, Preschool | 2 | 2012 | 1418 | 0.130 |
Why?
|
Angiography | 2 | 2012 | 15 | 0.130 |
Why?
|
Medicaid | 1 | 2017 | 109 | 0.130 |
Why?
|
Recurrence | 3 | 2011 | 131 | 0.130 |
Why?
|
Body Mass Index | 2 | 2018 | 854 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2014 | 6 | 0.120 |
Why?
|
Cardiovascular Agents | 2 | 2011 | 20 | 0.120 |
Why?
|
Critical Illness | 1 | 2014 | 38 | 0.120 |
Why?
|
Diabetes Complications | 2 | 2011 | 90 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2012 | 8 | 0.110 |
Why?
|
Syncope | 1 | 2012 | 3 | 0.110 |
Why?
|
Mediastinum | 1 | 2012 | 5 | 0.110 |
Why?
|
Angioplasty, Balloon | 2 | 2020 | 4 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 1 | 2012 | 11 | 0.110 |
Why?
|
Drug Eruptions | 1 | 2012 | 8 | 0.110 |
Why?
|
Tachycardia, Ventricular | 1 | 2012 | 12 | 0.110 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2011 | 110 | 0.110 |
Why?
|
Webcasts as Topic | 1 | 2012 | 2 | 0.110 |
Why?
|
Child | 2 | 2012 | 3131 | 0.110 |
Why?
|
Safety Management | 1 | 2012 | 18 | 0.100 |
Why?
|
Thiophenes | 1 | 2012 | 31 | 0.100 |
Why?
|
Tissue Survival | 1 | 2012 | 2 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2012 | 149 | 0.100 |
Why?
|
Stress, Mechanical | 1 | 2012 | 113 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 16 | 0.100 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2012 | 6 | 0.100 |
Why?
|
Reoperation | 1 | 2011 | 24 | 0.100 |
Why?
|
Consumer Health Information | 1 | 2012 | 22 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2012 | 56 | 0.100 |
Why?
|
Diverticulum | 1 | 2011 | 2 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 268 | 0.100 |
Why?
|
Piperazines | 1 | 2012 | 111 | 0.100 |
Why?
|
Cause of Death | 3 | 2020 | 156 | 0.100 |
Why?
|
Recovery of Function | 1 | 2012 | 88 | 0.100 |
Why?
|
Transurethral Resection of Prostate | 1 | 2011 | 2 | 0.100 |
Why?
|
Healthcare Disparities | 1 | 2016 | 494 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2011 | 9 | 0.100 |
Why?
|
Cannabinoids | 1 | 2012 | 56 | 0.100 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 2721 | 0.100 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 62 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 803 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2011 | 36 | 0.090 |
Why?
|
Embolism | 1 | 2010 | 1 | 0.090 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 400 | 0.090 |
Why?
|
Vena Cava, Superior | 1 | 2010 | 4 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2010 | 9 | 0.090 |
Why?
|
Patient Selection | 1 | 2012 | 164 | 0.090 |
Why?
|
Nuclear Medicine | 1 | 2010 | 5 | 0.090 |
Why?
|
Surgical Instruments | 1 | 2010 | 4 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2010 | 28 | 0.090 |
Why?
|
Hospitals, Veterans | 1 | 2010 | 15 | 0.090 |
Why?
|
Microspheres | 1 | 2010 | 49 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2010 | 52 | 0.090 |
Why?
|
Blood Glucose | 2 | 2009 | 353 | 0.090 |
Why?
|
Aspirin | 1 | 2010 | 49 | 0.090 |
Why?
|
Coronary Circulation | 1 | 2009 | 27 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 481 | 0.080 |
Why?
|
Albuminuria | 2 | 2007 | 76 | 0.080 |
Why?
|
Drug Carriers | 1 | 2009 | 125 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2008 | 27 | 0.080 |
Why?
|
Antioxidants | 1 | 2011 | 416 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 1039 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 202 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2007 | 28 | 0.070 |
Why?
|
Endothelium, Vascular | 4 | 2012 | 237 | 0.070 |
Why?
|
Water | 1 | 2009 | 296 | 0.070 |
Why?
|
Pacemaker, Artificial | 1 | 2007 | 17 | 0.070 |
Why?
|
Patient Compliance | 1 | 2008 | 212 | 0.070 |
Why?
|
Dyspnea | 1 | 2007 | 18 | 0.070 |
Why?
|
Chest Pain | 1 | 2007 | 37 | 0.070 |
Why?
|
Exercise Test | 1 | 2007 | 67 | 0.070 |
Why?
|
Respiration | 1 | 2007 | 58 | 0.070 |
Why?
|
Peptides | 1 | 2009 | 320 | 0.070 |
Why?
|
Proteins | 1 | 2009 | 369 | 0.070 |
Why?
|
Brachial Artery | 1 | 2006 | 28 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 225 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2007 | 208 | 0.070 |
Why?
|
Fatigue | 1 | 2007 | 83 | 0.070 |
Why?
|
Single-Blind Method | 3 | 2011 | 55 | 0.070 |
Why?
|
Meditation | 1 | 2006 | 26 | 0.070 |
Why?
|
Yoga | 1 | 2006 | 27 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 1067 | 0.070 |
Why?
|
Infant | 1 | 2008 | 1046 | 0.060 |
Why?
|
Total Quality Management | 1 | 2004 | 9 | 0.060 |
Why?
|
Cardiology Service, Hospital | 1 | 2004 | 3 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 441 | 0.060 |
Why?
|
Ultrasonography | 1 | 2003 | 112 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2022 | 39 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2016 | 583 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2006 | 583 | 0.050 |
Why?
|
Precipitating Factors | 1 | 2020 | 3 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2020 | 9 | 0.050 |
Why?
|
Hirudins | 1 | 2020 | 2 | 0.050 |
Why?
|
Hospital Charges | 1 | 2020 | 13 | 0.050 |
Why?
|
Patient Transfer | 1 | 2020 | 23 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2019 | 8 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2020 | 54 | 0.040 |
Why?
|
Home Care Services | 1 | 2020 | 33 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2019 | 39 | 0.040 |
Why?
|
Patient Discharge | 1 | 2020 | 93 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2020 | 208 | 0.040 |
Why?
|
Syndrome | 1 | 2019 | 74 | 0.040 |
Why?
|
Mortality | 1 | 2020 | 145 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 160 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2020 | 515 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2020 | 174 | 0.040 |
Why?
|
ROC Curve | 1 | 2018 | 138 | 0.040 |
Why?
|
Recreation | 1 | 2018 | 32 | 0.040 |
Why?
|
Population Surveillance | 1 | 2019 | 238 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 2017 | 7 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 739 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 562 | 0.040 |
Why?
|
Anxiety Disorders | 1 | 2020 | 309 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 191 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2016 | 242 | 0.030 |
Why?
|
Odds Ratio | 1 | 2016 | 534 | 0.030 |
Why?
|
Hyperemia | 1 | 2013 | 3 | 0.030 |
Why?
|
Hyperplasia | 1 | 2011 | 38 | 0.030 |
Why?
|
Scavenger Receptors, Class E | 1 | 2011 | 4 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2012 | 119 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 143 | 0.020 |
Why?
|
Angiotensin II | 1 | 2011 | 97 | 0.020 |
Why?
|
Internet | 1 | 2012 | 211 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2010 | 55 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 431 | 0.020 |
Why?
|
Greece | 1 | 2009 | 18 | 0.020 |
Why?
|
Food Deprivation | 1 | 2009 | 30 | 0.020 |
Why?
|
Ticlopidine | 1 | 2009 | 15 | 0.020 |
Why?
|
Fasting | 1 | 2009 | 54 | 0.020 |
Why?
|
Animals | 3 | 2011 | 15081 | 0.020 |
Why?
|
Veterans | 1 | 2009 | 122 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2007 | 5 | 0.020 |
Why?
|
Emergencies | 1 | 2007 | 24 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2007 | 18 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2007 | 97 | 0.020 |
Why?
|
Inflammation | 1 | 2012 | 618 | 0.020 |
Why?
|
Forecasting | 1 | 2007 | 128 | 0.020 |
Why?
|
Brachytherapy | 1 | 2006 | 7 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2007 | 68 | 0.020 |
Why?
|
Vasodilation | 1 | 2006 | 65 | 0.020 |
Why?
|
Sirolimus | 1 | 2006 | 60 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 76 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2006 | 60 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2006 | 149 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2011 | 938 | 0.020 |
Why?
|
Heart Rate | 1 | 2006 | 253 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 204 | 0.020 |
Why?
|
Lipids | 1 | 2006 | 235 | 0.020 |
Why?
|
Connecticut | 1 | 2004 | 14 | 0.020 |
Why?
|
Time and Motion Studies | 1 | 2004 | 9 | 0.020 |
Why?
|
Pilot Projects | 1 | 2006 | 661 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 1398 | 0.010 |
Why?
|
Program Evaluation | 1 | 2004 | 339 | 0.010 |
Why?
|
Blood Pressure | 1 | 2006 | 646 | 0.010 |
Why?
|
Mice | 1 | 2011 | 5913 | 0.010 |
Why?
|